StockData
Humacyte, Inc. logo

Humacyte, Inc. (HUMA) stock

HUMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.50−0.04 (-7.27%)

Close on Nov 17, 2026Market cap $139.18MP/E –Yield –

Humacyte price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Humacyte's price to sales ratio was 77.5× on Nov 11, 2026, against 136.5× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202677.5×−19.6
2025Dec 31, 202597.1×–

More Humacyte figures

See a number that looks wrong?